D-0260-2021 Class III Terminated
Recall Details
- Product Type
- Drugs
- Report Date
- February 24, 2021
- Initiation Date
- January 29, 2021
- Termination Date
- February 10, 2022
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 17,664 bottles
Product Description
Auryxia (ferric citrate) tablets, 210 mg*, 200 tablets bottle, RX ONLY, Manufactured for and distributed by: KERYX BIOPHARMACEUTICALS, INC., 245 First Street, Suite 1400, Cambridge, MA 02142, USA, NDC 59922-0631-01.
Reason for Recall
Failed Dissolution Specifications
Distribution Pattern
Nationwide.
Code Information
Lots #: CDKSN, CDPPH, Exp January 2022; Lot #: CDPPK, Exp February 2022.